Discuss This Drug

aclidinium

CHEBI:CHEBI_65346

Definition

A carboxylic ester obtained by formal condensation between the carboxy group of 2-hydroxy(di-2-thienyl)acetic acid and the hydroxy group of N-(3-phenoxypropyl)-3-quinuclidinol. Used as its bromide salt for the long-term maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD).

Chemical Information

Molecular Formula
C26H30NO4S2
Molecular Mass
484.65100
Charge
+1
SMILES
OC(C(=O)O[C@H]1C[N+]2(CCCOc3ccccc3)CCC1CC2)(c1cccs1)c1cccs1
InChI
InChI=1S/C26H30NO4S2/c28-25(26(29,23-9-4-17-32-23)24-10-5-18-33-24)31-22-19-27(14-11-20(22)12-15-27)13-6-16-30-21-7-2-1-3-8-21/h1-5,7-10,17-18,20,22,29H,6,11-16,19H2/q+1/t20?,22-,27?/m0/s1
InChIKey
ASMXXROZKSBQIH-VITNCHFBSA-N

Alternative Names

  • (3R)-3-[2-hydroxy(di-2-thienyl)acetoxy]-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
1303098
oboInOwl#hasDbXref
PMID:21628603
core#notation
CHEBI:65346

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

has_treatment
http://purl.obolibrary.org/obo/DOID_850
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect31339
owl#annotatedSource
t269606
owl#someValuesFrom
t3463494
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
1303098
oboInOwl#id
CHEBI:65346
oboInOwl#hasDbXref
PMID:21628603
rxcui
2205104
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20241231
dosage_form
POWDER, METERED
route
RESPIRATORY (INHALATION)
pharm_class
Cholinergic Antagonists [MoA]
marketing_start_date
20140326
package_marketing_start_date
26-MAR-14
active_ingredient_name
ACLIDINIUM BROMIDE
unii
UQW7UF9N91
active_ingredient_strength
12 ug/1
labeler_name
INKE S.A.
manufacturer_name
Covis Pharma US, Inc
generic_name
Aclidinium Bromide
brand_name
DUAKLIR PRESSAIR
brand_name_base
DUAKLIR PRESSAIR
product_ndc
70515-001
application_number
NDA210595
spl_id
2eba3089-28b4-4190-9fba-2511246cfd16
package_ndc
70515-001-03
package_description
1 POUCH in 1 CARTON (70515-001-03) / 1 INHALER in 1 POUCH / 30 POWDER, METERED in 1 INHALER
spl_set_id
2eba3089-28b4-4190-9fba-2511246cfd16
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_48876
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#has_functional_parent
http://purl.obolibrary.org/obo/CHEBI_115239
core#notation
CHEBI:65346
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class